collection
MENU ▼
Read by QxMD icon Read
search

SPRINT | Page 2

shared collection
38 papers 25 to 100 followers Papers related to the trial "Randomized Trial of Intensive versus Standard Blood-Pressure Control"
https://www.readbyqxmd.com/read/26685302/sprint-results-are-life-saving-guideline-changing-and-hypertension-research-intensifying
#21
EDITORIAL
Costas Tsioufis, Dimitris Tousoulis
No abstract text is available yet for this article.
November 2015: Hellenic Journal of Cardiology: HJC, Hellēnikē Kardiologikē Epitheōrēsē
https://www.readbyqxmd.com/read/26708353/sprint-for-heart-failure
#22
EDITORIAL
Michael W Rich
No abstract text is available yet for this article.
February 2016: Journal of Cardiac Failure
https://www.readbyqxmd.com/read/26597221/sprint-proves-that-lower-is-better-for-nondiabetic-high-risk-patients-but-at-a-price
#23
EDITORIAL
Ernesto L Schiffrin, David A Calhoun, John M Flack
No abstract text is available yet for this article.
January 2016: American Journal of Hypertension
https://www.readbyqxmd.com/read/26606951/hypertension-sprinting-towards-a-new-target-for-blood-pressure-control
#24
Karina Huynh
No abstract text is available yet for this article.
January 2016: Nature Reviews. Cardiology
https://www.readbyqxmd.com/read/26655222/treatment-of-hypertension-in-patients-with-coronary-artery-disease-a-case-based-summary-of-the-2015-aha-acc-ash-scientific-statement
#25
REVIEW
Clive Rosendorff
The 2015 American Heart Association/American College of Cardiology/American Society of Hypertension Scientific Statement "Treatment of Hypertension in Patients with Coronary Artery Disease" is summarized in the context of a clinical case. The Statement deals with target blood pressures, and the optimal agents for the treatment of hypertension in patients with stable angina, in acute coronary syndromes, and in patients with ischemic heart failure. In all cases, the recommended blood pressure target is <140/90 mm Hg, but <130/80 mm Hg may be appropriate, especially in those with a history of a previous myocardial infarction or stroke, or at high risk for developing either...
April 2016: American Journal of Medicine
https://www.readbyqxmd.com/read/26655875/sprint-the-race-for-optimal-blood-pressure-control
#26
EDITORIAL
Thomas F Lüscher, Isabella Sudano
No abstract text is available yet for this article.
March 21, 2016: European Heart Journal
https://www.readbyqxmd.com/read/26562046/generalizability-of-sprint-results-to-the-u-s-adult-population
#27
RANDOMIZED CONTROLLED TRIAL
Adam P Bress, Rikki M Tanner, Rachel Hess, Lisandro D Colantonio, Daichi Shimbo, Paul Muntner
BACKGROUND: In SPRINT (Systolic Blood Pressure Intervention Trial), a systolic blood pressure (SBP) goal of <120 mm Hg resulted in lower cardiovascular disease (CVD) risk compared with an SBP goal of <140 mm Hg. OBJECTIVES: The purpose of this study was to estimate the prevalence, number, and characteristics of U.S. adults meeting SPRINT eligibility criteria and determine the broader population to whom SPRINT could be generalized. METHODS: We conducted a cross-sectional, population-based study using data from the National Health and Nutrition Examination Survey, 2007 to 2012...
February 9, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/26506129/the-sprint-trial
#28
Paolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi
No abstract text is available yet for this article.
October 2015: Journal of the American Society of Hypertension: JASH
https://www.readbyqxmd.com/read/26553785/managing-hypertension-in-patients-with-ckd-a-marathon-not-a-sprint
#29
Glenn M Chertow, Srinivasan Beddhu, Julia B Lewis, Robert D Toto, Alfred K Cheung
In this manuscript, nephrologist-investigators from one of five Clinical Center Networks of the Systolic Blood Pressure Intervention Trial (SPRINT) provide background information and context on the intensity of anti-hypertensive therapy in conjunction with the release of detailed results from SPRINT's primary analysis. The authors highlight published evidence on the safety and efficacy of differing intensities of anti-hypertensive therapy in mild to moderate CKD, where SPRINT will help to inform practice, as well as where gaps in evidence will remain...
January 2016: Journal of the American Society of Nephrology: JASN
https://www.readbyqxmd.com/read/26553232/sprint-or-false-start-toward-a-lower-universal-treated-blood-pressure-target-in-hypertension
#30
REVIEW
Murray Esler
No abstract text is available yet for this article.
February 2016: Hypertension
https://www.readbyqxmd.com/read/26553234/sprint-trial-results-latest-news-in-hypertension-management
#31
REVIEW
William C Cushman, Paul K Whelton, Lawrence J Fine, Jackson T Wright, David M Reboussin, Karen C Johnson, Suzanne Oparil
No abstract text is available yet for this article.
February 2016: Hypertension
https://www.readbyqxmd.com/read/26553235/sprint-what-remains-unanswered-and-where-do-we-go-from-here
#32
REVIEW
Daniel W Jones, Lyssa Weatherly, John E Hall
No abstract text is available yet for this article.
February 2016: Hypertension
https://www.readbyqxmd.com/read/20228401/effects-of-intensive-blood-pressure-control-in-type-2-diabetes-mellitus
#33
RANDOMIZED CONTROLLED TRIAL
William C Cushman, Gregory W Evans, Robert P Byington, David C Goff, Richard H Grimm, Jeffrey A Cutler, Denise G Simons-Morton, Jan N Basile, Marshall A Corson, Jeffrey L Probstfield, Lois Katz, Kevin A Peterson, William T Friedewald, John B Buse, J Thomas Bigger, Hertzel C Gerstein, Faramarz Ismail-Beigi
BACKGROUND: There is no evidence from randomized trials to support a strategy of lowering systolic blood pressure below 135 to 140 mm Hg in persons with type 2 diabetes mellitus. We investigated whether therapy targeting normal systolic pressure (i.e., <120 mm Hg) reduces major cardiovascular events in participants with type 2 diabetes at high risk for cardiovascular events. METHODS: A total of 4733 participants with type 2 diabetes were randomly assigned to intensive therapy, targeting a systolic pressure of less than 120 mm Hg, or standard therapy, targeting a systolic pressure of less than 140 mm Hg...
April 29, 2010: New England Journal of Medicine
https://www.readbyqxmd.com/read/26551394/redefining-blood-pressure-targets-sprint-starts-the-marathon
#34
EDITORIAL
Vlado Perkovic, Anthony Rodgers
Blood pressure is a potent determinant of cardiovascular risk, but the most appropriate targets for blood-pressure lowering have long been debated. Observational studies with a low risk of confounding have shown a linear relationship between blood pressure and cardiovascular risk down to 115/75 mm..
November 26, 2015: New England Journal of Medicine
https://www.readbyqxmd.com/read/26551272/a-randomized-trial-of-intensive-versus-standard-blood-pressure-control
#35
RANDOMIZED CONTROLLED TRIAL
Jackson T Wright, Jeff D Williamson, Paul K Whelton, Joni K Snyder, Kaycee M Sink, Michael V Rocco, David M Reboussin, Mahboob Rahman, Suzanne Oparil, Cora E Lewis, Paul L Kimmel, Karen C Johnson, David C Goff, Lawrence J Fine, Jeffrey A Cutler, William C Cushman, Alfred K Cheung, Walter T Ambrosius
BACKGROUND: The most appropriate targets for systolic blood pressure to reduce cardiovascular morbidity and mortality among persons without diabetes remain uncertain. METHODS: We randomly assigned 9361 persons with a systolic blood pressure of 130 mm Hg or higher and an increased cardiovascular risk, but without diabetes, to a systolic blood-pressure target of less than 120 mm Hg (intensive treatment) or a target of less than 140 mm Hg (standard treatment). The primary composite outcome was myocardial infarction, other acute coronary syndromes, stroke, heart failure, or death from cardiovascular causes...
November 26, 2015: New England Journal of Medicine
https://www.readbyqxmd.com/read/26551058/a-sprint-to-the-finish
#36
EDITORIAL
Jeffrey M Drazen, Stephen Morrissey, Edward W Campion, John A Jarcho
When investigators enroll patients in a clinical study, they make an implicit contract with each participant. Through the data and safety monitoring board (DSMB) mechanism, they fulfill the first part of the contract — protecting the participant from avoidable harm that might result from..
November 26, 2015: New England Journal of Medicine
https://www.readbyqxmd.com/read/26550920/time-to-reassess-blood-pressure-goals
#37
Aram V Chobanian
More than 70 million people in the United States and more than 1 billion worldwide have hypertension — defined by a systolic blood pressure of at least 140 mm Hg and a diastolic blood pressure of at least 90 mm Hg — and the numbers are increasing steadily. Despite remarkable advances in..
November 26, 2015: New England Journal of Medicine
https://www.readbyqxmd.com/read/24902920/the-design-and-rationale-of-a-multicenter-clinical-trial-comparing-two-strategies-for-control-of-systolic-blood-pressure-the-systolic-blood-pressure-intervention-trial-sprint
#38
RANDOMIZED CONTROLLED TRIAL
Walter T Ambrosius, Kaycee M Sink, Capri G Foy, Dan R Berlowitz, Alfred K Cheung, William C Cushman, Lawrence J Fine, David C Goff, Karen C Johnson, Anthony A Killeen, Cora E Lewis, Suzanne Oparil, David M Reboussin, Michael V Rocco, Joni K Snyder, Jeff D Williamson, Jackson T Wright, Paul K Whelton
BACKGROUND: High blood pressure is an important public health concern because it is highly prevalent and a risk factor for adverse health outcomes, including coronary heart disease, stroke, decompensated heart failure, chronic kidney disease, and decline in cognitive function. Observational studies show a progressive increase in risk associated with blood pressure above 115/75 mm Hg. Prior research has shown that reducing elevated systolic blood pressure lowers the risk of subsequent clinical complications from cardiovascular disease...
October 2014: Clinical Trials: Journal of the Society for Clinical Trials
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"